Dubai-based healthcare platform TruDoc raises $15 million in pre-Series B funding led by Al Sahel Investment to expand across GCC markets and develop AI diagnostic capabilities. The telemedicine company has processed over 2.5 million consultations since 2018.
TruDoc, a Dubai-based healthcare technology platform, has raised $15 million in a pre-Series B funding round led by Al Sahel Investment, with participation from existing investors including Oqal Capital and Abjad Holding. The funding will support the company's expansion across the Gulf Cooperation Council markets and development of artificial intelligence capabilities for diagnostic services.
Founded in 2018 by Dr. Ahmed Mahmoud and Ramy Hassan, TruDoc operates a comprehensive telemedicine platform that connects patients with licensed healthcare professionals across the UAE and Saudi Arabia. The platform has processed over 2.5 million consultations since inception, serving both individual patients and corporate clients through workplace wellness programs. The company's technology infrastructure includes electronic health records management, prescription fulfillment services, and integration with local pharmacy networks.
The funding round reflects growing investor confidence in MENA's healthcare technology sector, which has attracted over $180 million in venture capital during 2024 according to data from MAGNiTT. TruDoc's raise follows significant funding rounds for regional peers including Saudi Arabia's Altibbi, which secured $44 million in Series B funding in 2023, and UAE-based Vezeeta, which raised $40 million before its acquisition by Al Moayed Technologies in 2022.
Dr. Ahmed Mahmoud, co-founder and CEO of TruDoc, stated that the platform has achieved monthly recurring revenue growth of 35% over the past twelve months, driven primarily by enterprise contracts with government entities and large corporations. The company currently employs 120 people across offices in Dubai and Riyadh, with plans to expand its workforce to 180 employees by the end of 2025.
The fresh capital will fund TruDoc's development of machine learning algorithms designed to assist healthcare professionals with preliminary diagnosis and treatment recommendations. The company is collaborating with United Arab Emirates University's College of Medicine and Health Sciences to validate these AI tools against clinical datasets from regional patient populations. Additionally, TruDoc plans to launch services in Qatar and Bahrain during the second quarter of 2025, requiring regulatory approvals from respective health authorities.
TruDoc's revenue model combines subscription fees from healthcare providers, transaction fees from patient consultations, and enterprise contracts for corporate wellness programs. The company reports that enterprise clients, including Emirates and ADNOC, account for approximately 60% of total revenue. Monthly active users have grown to 85,000 across the platform's mobile applications and web portal, with average consultation duration of 18 minutes.
Healthcare regulators across the Gulf region have implemented frameworks supporting telemedicine services, with the Dubai Health Authority and Saudi Ministry of Health establishing licensing requirements for digital health platforms. TruDoc maintains regulatory compliance across multiple jurisdictions, including data localization requirements and healthcare professional verification standards mandated by local authorities.
The regional healthcare market is valued at approximately $84 billion according to research from Frost & Sullivan, with digital health services representing less than 3% of total healthcare spending. Government initiatives including Saudi Arabia's Vision 2030 and the UAE's National Health Strategy 2031 have established targets for increasing digital healthcare adoption, creating regulatory support for platforms like TruDoc.
Khalid Al Rumaithi, managing partner at Al Sahel Investment, noted that TruDoc's focus on regulatory compliance and integration with existing healthcare infrastructure differentiated the company from other regional telemedicine providers. The investment firm, which manages over $800 million in assets focused on technology and healthcare sectors across the MENA region, previously invested in healthcare companies including Meddy and okadoc.
